本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Seres Therapeutics, Inc.

0.6898
+0.05148.05%
盘后0.6600-0.0298-4.32%19:11 EDT
成交量:81.23万
成交额:54.85万
市值:1.18亿
市盈率:-3.93
高:0.6900
开:0.6500
低:0.6400
收:0.6384
数据加载中...

公司资料

公司名字:
Seres Therapeutics, Inc.
交易所:
NASDAQ
成立时间:
2010
员工人数:
233
公司地址:
101 Cambridgepark Drive,Cambridge,Massachusetts,United States
邮编:
02140
电话:
传真:
- -
简介:
Seres Therapeutics, Inc.于2010年10月根据特拉华州法律注册成立。该公司是一家商业阶段的微生物组疗法公司,专注于一类新型生物药物的开发和商业化,这些药物旨在通过调节微生物组来治疗疾病,通过将被破坏的微生物组的功能修复到非疾病状态来恢复健康。该公司还在设计微生物组疗法,这些疗法经过优化,可以去定植病原体并调节宿主功能,以减少和预防感染并诱导免疫耐受。

董事

名称
职位
Eric D. Shaff
President, Chief Executive Officer and Director
Stephen Berenson
Chairman of the Board
Dennis A. Ausiello
Director
Gregory Behar
Director
Kurt C. Graves
Director
Meryl S. Zausner
Director
Paul R. Biondi
Director
Richard N. Kender
Director
Willard H. Dere
Director

股东

名称
职位
Eric D. Shaff
President, Chief Executive Officer and Director
Marcus Chapman
Senior Vice President, Finance and Principal Financial and Accounting Officer
David S. Ege
Executive Vice President and Chief Technology Officer
Lisa von Moltke
Executive Vice President and Chief Medical Officer
Matthew Henn
Executive Vice President and Chief Scientific Officer
Teresa L. Young
Executive Vice President, Chief Commercial and Strategy Officer
Thomas J. DesRosier
Executive Vice President and Chief Legal Officer